Quick Takeaways
- Hudson Bay Capital Management LP filed SCHEDULE 13G/A for Keenova Therapeutics plc Ordinary Shares, $0.01 par value (MNKTQ).
- Disclosed ownership: 5.2%.
- Date of event: 31 Dec 2025.
Hudson Bay Capital Management LP - 31 Dec 2025 SCHEDULE 13G/A Report for Keenova Therapeutics plc Ordinary Shares, $0.01 par value (MNKTQ)
- Filing Manager
- Hudson Bay Capital Management LP
- Reporting Manager
- Hudson Bay Capital Management LP
- Symbol
- MNKTQ
- Shares outstanding
- 39,494,008 shares
- Disclosed Ownership
- 2,049,739 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 11 Feb 2026, 13:20:52 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 07 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Hudson Bay Capital Management LP disclosed 5.2% ownership in Keenova Therapeutics plc Ordinary Shares, $0.01 par value (MNKTQ) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 07 Aug 2025.
- Current filing was accepted on 11 Feb 2026, 13:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 5.2% | 2,049,739 | 0 | 2,049,739 | /s/ Sander Gerber | Sander Gerber, Authorized Signatory | |
| Sander Gerber | 5.2% | 2,049,739 | 0 | 2,049,739 | /s/ Sander Gerber | Sander Gerber, Individually |